Comparative mutagenicity of 7H-dibenzo[c,g]carbazole and two derivatives in Muta(TM) mouse liver and skin

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 417, Issue 2-3, 1998, Pages 129-140

  Renault, Dominique ^a   Tombolan, Françoise ^a,b   Brault, Dominique ^a   Périn, François ^c   Thybaud, Véronique ^a  

^a SANOFI   (France)

^b CNRS   (France)

^c INSTITUT CURIE   (France)

Author keywords

Dibenzocarbazole; Liver; Mura(TM) Mouse; Skin

Indexed keywords

7H DIBENZO[C,G]CARBAZOLE; CARBAZOLE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; GENE MUTATION; LIVER; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN; TRANSGENIC MOUSE;

ADMINISTRATION, CUTANEOUS; ANIMALS; CARBAZOLES; CARCINOGENS; INJECTIONS, SUBCUTANEOUS; LAC OPERON; LIVER; MALE; MICE; MUTAGENICITY TESTS; MUTATION; SKIN;

ANIMALIA; MUS MUSCULUS;

EID: 0031692087     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00101-6     Document Type: Article

References (40)

1. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Human: 7H-dibenzo[c,g]carbazole, Vol. 3, International Agency for Research into Cancer, Lyon, France.
2. D. Warshawsky, G. Talaska, W. Xue, J. Schneider, Comparative carcinogenicity, metabolism, mutagenicity, and DNA binding of 7H-dibenzo[c,g]carbazole and dibenz[a,j]acridine, Crit. Rev. Toxicol. 26 (1996) 213-249.
3. D. Warshawsky, W. Barkley, M.L. Miller, K. LaDow, A. Andringa, Carcinogenicity of 7H-dibenzo[c,g]carbazole, dibenz[a,j]acridine and benzo[a]pyrene in mouse skin and liver following topical application, Toxicology 93 (1994) 135-149.
4. P. Boffeta, N. Jourenkova, P. Gustavsson, Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons, Cancer Causes and Control 8 (1997) 444-472.
5. F. Périn, D. Valéro, V. Thybaud-Lambay, M.J. Plessis, F. Zajdela, Organ-specific, carcinogenic dibenzo[c,g]carbazole derivatives: discriminative response in S. typhimurium TA100 mutagenesis modulated by subcellular fractions of mouse liver, Mutat. Res. 198 (1988) 15-26.
6. M.E. Schurdak, K. Randerath, Effects of route of administration on tissue distribution of DNA adducts in mice: comparison of 7H-dibenzo[c,g]carbazole, benzo[a]pyrene and 2-acetylaminofluorene, Cancer Res. 49 (1989) 2633-2638.
7. G. Talaska, R. Reilma, M. Shamer, J. Hoon Roh, W. Xue, S.L. Fremont, D. Warshawsky, Tissue distribution of DNA adducts of 7H-dibenzo[c,g]carbazole and its derivatives in mice following topical application, Chem. Res. Toxicol. 7 (1994) 374-379.
8. O. Périn-Roussel, N. Barat, F. Zajdela, F. Périn, Tissue-specific differences in adduct formation by hepatocarcinogenic and sarcomatogenic derivatives of 7H-dibenzo[c,g]carbazole in mouse parenchymal and nonparenchymal cells, Environ. Mol. Mutagen. 29 (1997) 246-256.
9. A. Gabelova, O. Périn-Roussel, Y. Jounaidi, F. Périn, DNA adduct formation in primary embryo cells induced by 7H-dibenzo[c,g]carbazole and its organ-specific carcinogenic derivatives, Environ. Mol. Mutagen. 30 (1997) 56-64.
10. D. Valéro, F. Périn, M.J. Plessis, F. Zajdela, Sexual differences in the expression of γ-glutamyltranspeptidase during 5,9-dimethyldibenzo[c,g]carbazole induced hepatocarcinogenesis in mice, Cancer Lett. 27 (1985) 181-197.
11. D. Szafarz, F. Périn, D. Valéro, F. Zajdela, Structure and carcinogenicity of dibenzo[c,g]carbazole derivatives, Biosci. Rep. 8 (1988) 633-643.
12. O. Périn-Roussel, F. Périn, N. Barat, M.J. Plessis, F. Zajdela, Interaction of 7H-dibenzo[c,g]carbazole and its organospecific derivatives with hepatic mitochondrial and nuclear DNA in the mouse, Environ. Mol. Mutagen. 25 (1995) 202-210.
13. J.A. Gossen, W.J.F. de Leeuw, C.H.T. Tan, E.C. Zwarthoff, F. Berends, P.H.M. Lohman, D.L. Knook, J. Vijg, Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo, Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7971-7975.
14. J.A. Gossen, J. Vijg, A selective system for lacZ-phage using a galactose-sensitive E. coli host, Biotechniques 14 (1993) 326-330.
15. F. Périn, M. Dufour, J. Mispelter, B. Ekert, C. Künneke, F. Oesch, F. Zajdela, Heterocyclic polycyclic aromatic hydrocarbon carcinogenesis: 7H-dibenzo[c,g]carbazole metabolism by microsomal enzymes from mouse and rat liver, Chem. Biol. Interact. 35 (1981) 267-284.
16. D. Valéro, F. Périn, F. Zajdela, Binding of 5,9-dimethyldibenzo[c,g]carbazole, a potent hepatocarcinogen, to mouse hepatic cytosolic proteins, Carcinogenesis 4 (1983) 1333-1340.
17. F. Périn, D. Valéro, J. Mispelter, F. Zajdela, In vitro metabolism of N-methyldibenzo[c,g]carbazole a potent sarcomatogen devoid of hepatotoxic and hepatocarcinogenic properties, Chem. Biol. Interact. 48 (1984) 281-295.
18. D. Brault, C. Bouilly, D. Renault, V. Thybaud, Tissue-specific induction of mutations by acute oral administration of N-methyl-N′-nitro-N-nitrosoguanidine and β-propiolactone to the Muta™Mouse: preliminary data on stomach, liver and bone marrow, Mutat. Res. 360 (1996) 83-87.
19. Stratagene, Big Blue Transgenic Mouse Mutagenesis Assay Manual, Stratagene, La Jolla, CA, 1992.
20. D. Renault, D. Brault, V. Thybaud, Effect of ethylnitrosourea and methyl methanesulfonate on mutation frequency in Muta™Mouse germ cells (seminiferous tubule cells and epididymis spermatozoa), Mutat. Res. 388 (1997) 145-153.
21. J.D. Callahan, J.M. Short, Transgenic λLacI mutagenicity assay: statistical determination of sample size, Mutat. Res. 327 (1995) 201-208.
22. V. Morrison, J.A. Ashby, Preliminary evaluation of the performance of the Muta™Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays, Mutagenesis 9 (1994) 367-375.
23. N. Okada, A. Honda, M. Kawabata, N. Yajima, Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine, Mutagenesis 12 (1997) 179-184.
24. A.M. Lynch, N.J. Gooderham, A.R. Boobis, Organ distinctive mutagenicity in Muta™Mouse after short-term exposure to PhIP, Mutagenesis 5 (1996) 505-509.
25. 32P-postlabeling and Muta™Mouse lacZ-mutation data for DMBA and its K-region sulphur isostere: comparison with activities observed in standard genotoxicity assays, Mutat. Res. 292 (1993) 25-40.
26. T.M. Brooks, S.W. Dean, Detection of gene mutation in skin, stomach and liver of Muta™Mouse following oral or topical treatment with N-methyl-N′-nitro-N-nitrosoguanidine or 1-chloromethylpyrene: some preliminary observations, Mutagenesis 11 (1996) 529-532.
27. T. Sofuni, T. Suzuki, M. Hayashi, Initial consideration for use of transgenic mutation assays in a regulatory submission, Environ. Mol. Mutagen. 28 (1996) 443-446.
28. N.J. Gorelick, J.C. Mirsalis, A strategy for the application of transgenic rodent mutagenesis assays, Environ. Mol. Mutagen. 28 (1996) 434-442.
29. N.J. Gorelick, J.L. Andrews, M. Gu, B.W. Glickman, Mutational spectra in the lacI gene in skin from 7,12-dimethylbenz[a]anthracene-treated and untreated transgenic mice, Mol. Carcinog. 14 (1995) 53-62.
30. G.R. Douglas, J. Jiao, J.D. Gingerich, L.M. Soper, J.A. Gossen, Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice, Environ. Mol. Mutagen. 28 (1996) 317-324.
31. J. Jiao, G.R. Douglas, J.D. Gingerich, L.M. Soper, Analysis of tissue-specific lacZ mutations induced by N-nitrosodibenzylamine in transgenic mice, Carcinogenesis 18 (1997) 2239-2245.
32. W. Suter, R. Ahiabor, B. Blanco, F. Locher, F. Mantovani, M. Robinson, G. Sreenan, F. Staedtler, T. Swingler, A. Vignutelli, E. Perentes, Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue™ transgenic mouse mutation assay, Environ. Mol. Mutagen. 28 (1996) 354-362.
33. B.E. Butterworth, R.B. Conolly, K.T. Morgan, A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments, Cancer Lett. 93 (1995) 129-146.
34. M.L. Cunningham, H.B. Matthews, Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens, Toxicol. Lett. 82/83 (1995) 9-14.
35. M.L. Cunningham, Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens, Mutat. Res. 365 (1996) 59-69.
36. M.E. Schurdak, D.B. Stong, D. Warshawsky, K. Randerath, N-methylation reduces the DNA-binding activity of 7H-dibenzo[c,g]carbazole ∼300-fold in mouse liver but only ∼2-fold in skin: possible correlation with carcinogenic activity, Carcinogenesis 8 (1987) 1405-1410.
37. M.E. Schurdak, D. Warshawsky, Tissue-specific DNA adduct formation in mice treated with the environmental carcinogen, 7H-dibenzo[c,g]carbazole, Carcinogenesis 6 (1985) 1271-1274.
38. W.C. Parks, M.E. Schurdak, K. Randerath, V.M. Maher, J.J. McCormick, Human cell-mediated cytotoxicity, mutagenicity and DNA adduct formation of 7H-dibenzo[c,g]carbazole and its N-methyl derivative in diploid human fibroblasts, Cancer Res. 46 (1986) 4706-4711.
39. A.H.M. Kirby, P.R. Peacock, The influence of methylation on carcinogenic activity: I. N-methyl-3,4,5,6,-dibenzocarbazole, Br. J. Exp. Pathol. 27 (1946) 179-189.
40. J.R. Meier, D. Warshawsky, Comparison of blood protein and target organ DNA and protein binding following topical application of benzo[a]pyrene and 7H-dibenzo[c,g]carbazole to mice, Carcinogenesis 15 (1994) 2233-2240.